Results 11 to 20 of about 19,887 (300)

Access to direct-acting antivirals for the treatment of hepatitis C in a country with limited resources

Revista de Gastroenterología de México (English Edition), 2018
Aims: To estimate the number of patients that have access to treatment of hepatitis C with direct-acting antivirals in Argentina and evaluate the factors associated with the lack of access.
S. Marciano, L. Haddad, S.M. Borzi, C. D’Amico, L.A. Gaite, M.V. Aubone, M.E. Sirotinsky, N. Ratusnu, M.S. Frola, M.C. Aparicio, B. Ríos, M.N. Anselmo, R. Hansen, S. De Filippi, C. García Dans, L. de Labra, M.A. Peche, T.M. Strella, M. Ibáñez Duran, M.B. García Rosales, M. Dirchwolf, O.A. Galdame, A.C. Gadano   +22 more
doaj   +3 more sources

Norovirus antiviral discovery: host-modulators and direct-acting antivirals

, 2018
Human norovirus is a leading cause of acute gastroenteritis (AGE) worldwide and is estimated to be responsible for over 200,000 deaths each year. Norovirus infections are estimated to cost $60 billion in societal costs globally each year. Yet despite the substantial health and economic burden of norovirus, there is no vaccine or norovirus-specific ...
Enosi Tuipulotu, Daniel
openaire   +4 more sources

Effect of Direct-Acting Antivirals on Lipid and Glucose Metabolism in Chronic HCV Patients [PDF]

Minia Journal of Medical Research, 2019
Introduction: Hepatitis C virus (HCV) infection is a global public health burden, total global HCV prevalence is estimated at 2.5% (177 million of HCV infected adults), Considerable differences are present among different populations.
Mohammed Mohammed, Amr El-Sayed, Enas Kamal   +2 more
doaj   +1 more source

In a Real-Life Setting, Direct-Acting Antivirals to People Who Inject Drugs with Chronic Hepatitis C in Turkey. [PDF]

, 2022
Background: People who inject drugs (PWID) should be treated in order to eliminate hepatitis C virus in the world. The aim of this study was to compare direct-acting antivirals treatment of hepatitis C virus for PWID and non-PWID in a real-life setting.
Tosun, Selma, Baykam, Nurcan, Kenan Hizel, Üser, Ülkü, Sukran Kose, Gönal, Özgör, Sirmatel, Fatma, Nevin Ince, İnan, Dilara, Bodur, Hürrem, Ilkay Bozkurt, Batirel, Ayse, Namıduru, Mustafa, Duygu, Fazilet, Behice Kurtaran, Erben, Nurettin, Kömür, Süheyla, Ridvan Karaali, Namiduru, Mustafa, Sünnetçioğlu, Mahmut, Bodur, Hörrem, Esra Zerdali, Güner, Rahmet, Fehmi Tabak, Ayse Batirel, Çelebi, Güven, Guray Can, Alper Gunduz, Türker, Kamuran, Sari, Nagehan Didem, Yörük, Gülşen, Nefise Cuvalci Oztoprak, Göndöz, Alper, Gündüz, Alper, Fazilet Duygu, Hanefi Cem Gul, Dilara Inan, Karabay, Oğuz, Kumbasar Karaosmanoğlu, Hayat, Guven Celebi, Barut, Şener, Yildirim, Figen Sarigöl, User, Ulkö, Kurtaran, Behice, Kömör, Söheyla, Ozgur Gunal, Yusuf Onlen, Ayse Sagmak Tartar, Karsen, Hasan, Alper Sener, Gulsen Yoruk, Batırel, Ayşe, Fatma Sirmatel, Tayibe Bal, Celebi, Göven, Yildiz, Ilknur Esen, Figen Sarigul Yildirim, Sener Barut, Sarı, Nagehan Didem, Nurcan Baykam, Tartar, Ayse Sagmak, Yörök, Gölsen, Can, Güray, Hasan Karsen, Suheyla Komur, Iftihar Koksal, Sibel Kaya, Köksal, İftihar, Hayat Kumbasar Karaosmanoglu, Törker, Kamuran, Karaali, Rıdvan, Hızel, Kenan, Şenateş, Ebubekir, Tabak, Fehmi, Tansu Yamazhan, Oguz Karabay, Nurettin Erben, İnce, Nevin, Sönnetcioglu, Mahmut, Bal, Tayibe, Sarıgül Yıldırım, Figen, Hizel, Kenan, Ulku User, Kaya, Sibel, Karaosmanoglu, Hayat Kumbasar, Köse, Sökran, Hurrem Bodur, Göner, Rahmet, Bozkurt, İlkay, Rahmet Guner, Yamazhan, Tansu, Öztoprak, Nefise Cuvalci, Köse, ŞÜKRAN, Sırmatel, Fatma, Şener, Alper, Gül, Hanefi Cem, Ebubekir Senates, Karaali, Ridvan, Günal, Özgür, Zerdali, Esra, Sağmak Tartar, Ayşe, Yıldırım, Figen, Ilknur Esen Yildiz, Mahmut Sunnetcioglu, Selma Tosun, Mustafa Namiduru, Kamuran Turker, Can, Göray, Çuvalcı Öztoprak, Nefise, Önlen, Yusuf, Yıldız, İlknur Esen, Nagehan Didem Sari, Göl, Hanefi Cem   +112 more
core   +4 more sources

Direct-acting antivirals for flaviviruses.

, 2022
Direct-acting antivirals for flaviviruses.
Vinod RMT Balasubramaniam (12475307), Thamil Vaani Komarasamy (12475301), Nur Amelia Azreen Adnan (12475304), William James (208100)   +3 more
core   +1 more source

Lipid response in Hcv patients treated by direct acting antivirals [PDF]

Minia Journal of Medical Research, 2020
Background: sustained virological response (SVR) can be achived in high percentage of HCV patients with the availability of direct acting antiviral agents DAAs.
Asmaa Mohammed, Shereen Samy, Asmaa Ahmed, Hassan Mohey El-Din   +3 more
doaj   +1 more source

Barriers to treatment of failed or interferon ineligible patients in the era of DAA: single center study [PDF]

Clinical and Molecular Hepatology, 2017
Background/Aims Interferon-based treatment is not appropriate for a large number of patients with chronic hepatitis C for various medical and social reasons.
Kwang Il Seo, Byung Chul Yun, Weiquan James Li, Sang Uk Lee, Byung Hoon Han, Eun Taek Park   +5 more
doaj   +1 more source

Effectiveness of oral direct acting antivirals in elderly chronic hepatitis C patients: real-world data [PDF]

, 2020
Introduction: Objectives: Elderly cases have not been adequately representedin clinical trials with respect to chronic hepatitis C treatment. Extremely limited realworld data is available on new direct-acting antivirals in elderly patients. Herein, weaim
Çabalak, Mehmet, Bal, Tayibe
core   +1 more source

Reasons for not commencing direct-acting antiviral treatment despite unrestricted access for individuals with HIV and hepatitis C virus: a multinational, prospective cohort study. [PDF]

, 2023
BACKGROUND Individuals with HIV and hepatitis C virus (HCV) who remain untreated with direct-acting antivirals can contribute to HCV transmission and HCV-related mortality.
Salmon, Dominique, Hellard, Margaret, van der Valk, Marc, Martinello, Marianne, Matthews, Gail V, Stewart, Ashleigh, Klein, Marina B, Rauch, Andri, Stoove, Mark, Schinkel, Janke, Wittkop, Linda, InCHEHC study group, Berenguer, Juan, Sacks-Davis, Rachel, Smit, Colette, Boyd, Anders, Isfordink, Cas J, Lacombe, Karine, Doyle, Joseph S, van Santen, Daniela K   +19 more
core   +1 more source

Hepatitis C: sociodemographic and clinical profile of patients treated with direct-acting antivirals in a pharmaceutical office

Acta Scientiarum. Health Sciences, 2023
To report the sociodemographic and clinical profile of patients treated with direct-action antivirals (DAAs). Patients infected with hepatitis C virus in current treatment were followed up in a pharmaceutical office.
Karem Aline Pegoraro, Edson Luiz Folador, Dennis Armando Bertolini, Angela Maria Campagna   +3 more
doaj   +1 more source